Treatment of erosive oesophagitis with omeprazole: A comparison with different delivery system [1]

Digestive and Liver Disease

Volumn 33, Issue 8, 2001, Pages 731-

  Lu, C L ^a   Chen, T S ^a   Chen, C Y ^a   Chang, F Y ^a   Kang, L J ^a   Lee, S D ^a  

^a TAIPEI VETERANS GENERAL HOSPITAL   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

GELATIN; OMEPRAZOLE; PROTON PUMP INHIBITOR;

CHINESE; DRUG CAPSULE; DRUG DELIVERY SYSTEM; DRUG EFFICACY; DRUG FORMULATION; DRUG PELLET; DYSPHAGIA; ENDEMIC DISEASE; ENTERIC COATED TABLET; EPIGASTRIC PAIN; ESOPHAGITIS; GASTROESOPHAGEAL REFLUX; GRAM NEGATIVE INFECTION; HEALING; HEARTBURN; HELICOBACTER PYLORI; HUMAN; LACTOSE INTOLERANCE; LETTER; NASOGASTRIC TUBE; PATHOGENESIS; PREVALENCE; STATISTICAL ANALYSIS; SYMPTOM; TABLET DISINTEGRATION; TAIWAN; WELLBEING;

ANTI-ULCER AGENTS; DRUG DELIVERY SYSTEMS; ESOPHAGITIS; GASTROESOPHAGEAL REFLUX; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; OMEPRAZOLE; PROTON PUMPS;

EID: 17944380944     PISSN: 15908658     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1590-8658(01)80052-9     Document Type: Letter

References (4)

1. Pharmacodynamics and kinetics of meprazole MUPS 20 mg and pantoprazole 40 mg during repeated oral administration in Helicobacter pylori-negative subjects
2. Gastro-oesophageal reflux and Helicobacter pylori
3. Seroprevalence and associated risk factors of Helicobacter pylori infection in Taiwan
4. Helicobacter pylori colonization is not a major pathogenic factor for patients with non-ulcer dyspepsia